Ex parte QUIMBY, JR. et al. - Page 5




              Appeal No. 2000-1568                                                                                        
              Application 08/695,249                                                                                      
              interpreted by one possessing the ordinary level of skill in the pertinent art.”  In re Moore,              
              439 F.2d at 1235, 169 USPQ at 238.  Thus, the issue becomes would one skilled in the art                    
              have understood what is encompassed by the phrase “pathogenic components of said                            
              [biocontrol] agents.”                                                                                       
                     To that end, we find that the specification provides guidance through the example of                 
              one biocontrol agent, B.t. (Bacillus thuringiensis), wherein it discloses that the pathogenic               
              components include vegetative cells, spores, proteinaceous crystals.  Specification, p. 6,                  
              lines 18-22.  More importantly, however, we agree with the appellants that should a                         
              question arise as to whether a particular component of a biocontrol agent is pathogenic,                    
              one skilled in the art would have understood that simple testing of the component in                        
              question against the appropriate pest would resolve the issue.  Brief, p. 6.  Thus, we find                 
              that claim 1 sets forth with a reasonable degree of precision and particularity the “metes                  
              and bounds” of the appellants’ invention with the use of phrase “and pathogenic                             
              components of said [biocontrol] agents.”  In re Moore, 439 F.2d at 1235, 169 USPQ at                        
              238.                                                                                                        
                     Second, the examiner argues that claim 1 is vague and indefinite in the recitation of                
              “about.”  Answer, p. 4.  According to the examiner, it is not clear “how much less than or                  
              more than the 10 or the 65%” of the membrane stabilizing agent is intended to be included                   
              or excluded.  Id.  We find that this argument lacks merit.                                                  




                                                            5                                                             





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007